<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34921505</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-4833</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>188</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>American journal of medical genetics. Part A</Title>
          <ISOAbbreviation>Am J Med Genet A</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Truncating and zinc-finger variants in GLI2 are associated with hypopituitarism.</ArticleTitle>
        <Pagination>
          <StartPage>1065</StartPage>
          <EndPage>1074</EndPage>
          <MedlinePgn>1065-1074</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.a.62611</ELocationID>
        <Abstract>
          <AbstractText>Variants in transcription factor GLI2 have been associated with hypopituitarism and structural brain abnormalities, occasionally including holoprosencephaly (HPE). Substantial phenotypic variability and nonpenetrance have been described, posing difficulties in the counseling of affected families. We present three individuals with novel likely pathogenic GLI2 variants, two with truncating and one with a de novo missense variant p.(Ser548Leu), and review the literature for comprehensive phenotypic descriptions of individuals with confirmed pathogenic (a) intragenic GLI2 variants and (b) chromosome 2q14.2 deletions encompassing only GLI2. We show that most of the 31 missense variants previously reported as pathogenic are likely benign or, at most, low-risk variants. Four Zn-finger variants: p.(Arg479Gly), p.(Arg516Pro), p.(Gly518Lys), and p.(Tyr575His) were classified as likely pathogenic, and three other variants as possibly pathogenic: p.(Pro253Ser), p.(Ala593Val), and p.(Pro1243Leu). We analyze the phenotypic descriptions of 60 individuals with pathogenic GLI2 variants and evidence a morbidity spectrum that includes hypopituitarism (58%), HPE (6%) or other brain structure abnormalities (15%), orofacial clefting (17%) and dysmorphic facial features (35%). We establish that truncating and Zn-finger variants in GLI2 are associated with a high risk of hypopituitarism, and that a solitary median maxillary central incisor is part of the GLI2-related phenotypic variability. The most prevalent phenotypic feature is post-axial polydactyly (65%) which is also the mildest phenotypic expression of the condition, reported in many parents of individuals with systemic findings. Our approach clarifies clinical risks and the important messages to discuss in counseling for a pathogenic GLI2 variant.</AbstractText>
          <CopyrightInformation>© 2021 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Corder</LastName>
            <ForeName>Megan L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Health and Medicine, Lancaster University, Lancaster, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Berland</LastName>
            <ForeName>Siren</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Førsvoll</LastName>
            <ForeName>Jostein A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Stavanger University Hospital, Stavanger, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Banerjee</LastName>
            <ForeName>Indraneel</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Biology, Medicine and Health, Division of Developmental Biology and Medicine, University of Manchester and Manchester Academic Health Science Centre, Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Murray</LastName>
            <ForeName>Phil</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Biology, Medicine and Health, Division of Developmental Biology and Medicine, University of Manchester and Manchester Academic Health Science Centre, Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bratland</LastName>
            <ForeName>Eirik</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gokhale</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>North West Genomic Laboratory Hub, Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Houge</LastName>
            <ForeName>Gunnar</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Evolution, Infection and Genomics, School of Biological Sciences, University of Manchester, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Douzgou</LastName>
            <ForeName>Sofia</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-8890-7544</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Evolution, Infection and Genomics, School of Biological Sciences, University of Manchester, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>MR/T024119/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Med Genet A</MedlineTA>
        <NlmUniqueID>101235741</NlmUniqueID>
        <ISSNLinking>1552-4825</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C082593">GLI2 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051741">Kruppel-Like Transcription Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000075746">Zinc Finger Protein Gli2</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>J41CSQ7QDS</RegistryNumber>
          <NameOfSubstance UI="D015032">Zinc</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D016142" MajorTopicYN="Y">Holoprosencephaly</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007018" MajorTopicYN="Y">Hypopituitarism</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051741" MajorTopicYN="N">Kruppel-Like Transcription Factors</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015032" MajorTopicYN="N">Zinc</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000075746" MajorTopicYN="N">Zinc Finger Protein Gli2</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Culler-Jones syndrome</Keyword>
        <Keyword MajorTopicYN="Y">GLI2</Keyword>
        <Keyword MajorTopicYN="Y">combined pituitary hormone deficiency</Keyword>
        <Keyword MajorTopicYN="Y">holoprosencephaly</Keyword>
        <Keyword MajorTopicYN="Y">solitary median maxillary central incisor</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>20</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34921505</ArticleId>
        <ArticleId IdType="doi">10.1002/ajmg.a.62611</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Arnhold, I. J., França, M. M., Carvalho, L. R., Mendonca, B. B., &amp; Jorge, A. A. (2015). Role of GLI2 in hypopituitarism phenotype. Journal of Molecular Endocrinology, 54(3), R141-R150. https://doi.org/10.1530/JME-15-0009</Citation>
        </Reference>
        <Reference>
          <Citation>Babu, D., Fanelli, A., Mellone, S., Muniswamy, R., Wasniewska, M., Prodam, F., Petri, A., Bellone, S., Salerno, M. C., &amp; Giordano, M. (2019). Novel GLI2 mutations identified in patients with combined pituitary hormone deficiency (CPHD): Evidence for a pathogenic effect by functional characterization. Clinical Endocrinology, 90(3), 449-456. https://doi.org/10.1111/cen.13914</Citation>
        </Reference>
        <Reference>
          <Citation>Bear, K. A., Solomon, B. D., Antonini, S., Arnhold, I. J., França, M. M., Gerkes, E. H., Grange, D. K., Hadley, D. W., Jääskeläinen, J., Paulo, S. S., Rump, P., Stratakis, C. A., Thompson, E. M., Willis, M., Winder, T. L., Jorge, A. A., Roessler, E., &amp; Muenke, M. (2014). Pathogenic mutations in GLI2 cause a specific phenotype that is distinct from holoprosencephaly. Journal of Medical Genetics, 51(6), 413-418. https://doi.org/10.1136/jmedgenet-2013-102249</Citation>
        </Reference>
        <Reference>
          <Citation>Bertolacini, C. D., Ribeiro-Bicudo, L. A., Petrin, A., Richieri-Costa, A., &amp; Murray, J. C. (2012). Clinical findings in patients with GLI2 mutations: Phenotypic variability. Clinical Genetics, 81(1), 70-75. https://doi.org/10.1111/j.1399-0004.2010.01606.x</Citation>
        </Reference>
        <Reference>
          <Citation>Brauner, R., Bignon-Topalovic, J., Bashamboo, A., &amp; McElreavey, K. (2020). Pituitary stalk interruption syndrome is characterized by genetic heterogeneity. PLoS One, 15(12), e0242358. https://doi.org/10.1371/journal.pone.0242358</Citation>
        </Reference>
        <Reference>
          <Citation>Cohen, L. E. (2012). GLI2 mutations as a cause of hypopituitarism. Pediatric Endocrinology Reviews, 9(4), 706-709.</Citation>
        </Reference>
        <Reference>
          <Citation>Crapster, J. A., Hudgins, L., Chen, J. K., &amp; Gomez-Ospina, N. (2017). A novel missense variant in the GLI3 zinc finger domain in a family with digital anomalies. American Journal of Medical Genetics. Part A, 173(12), 3221-3225. https://doi.org/10.1002/ajmg.a.38415</Citation>
        </Reference>
        <Reference>
          <Citation>Culler, F. L., &amp; Jones, K. L. (1984). Hypopituitarism in association with postaxial polydactyly. The Journal of Pediatrics, 104(6), 881-884. https://doi.org/10.1016/s0022-3476(84)80486-2</Citation>
        </Reference>
        <Reference>
          <Citation>Debeer, P., Peeters, H., Driess, S., De Smet, L., Freese, K., Matthijs, G., Bornholdt, D., Devriendt, K., Grzeschik, K. H., Fryns, J. P., &amp; Kalff-Suske, M. (2003). Variable phenotype in Greig cephalopolysyndactyly syndrome: Clinical and radiological findings in 4 independent families and 3 sporadic cases with identified GLI3 mutations. American Journal of Medical Genetics. Part A, 120A(1), 49-58. https://doi.org/10.1002/ajmg.a.20018</Citation>
        </Reference>
        <Reference>
          <Citation>Demiral, M., Demirbilek, H., Unal, E., Durmaz, C. D., Ceylaner, S., &amp; Özbek, M. N. (2020). Ectopic posterior pituitary, polydactyly, Midfacial hypoplasia and multiple pituitary hormone deficiency due to a novel heterozygous IVS11-2A&gt;C(c.1957-2A&gt;C) mutation in the GLI2 gene. Journal of Clinical Research in Pediatric Endocrinology, 12(3), 319-328. https://doi.org/10.4274/jcrpe.galenos.2019.2019.0142</Citation>
        </Reference>
        <Reference>
          <Citation>Démurger, F., Ichkou, A., Mougou-Zerelli, S., Le Merrer, M., Goudefroye, G., Delezoide, A. L., Quélin, C., Manouvrier, S., Baujat, G., Fradin, M., Pasquier, L., Megarbané, A., Faivre, L., Baumann, C., Nampoothiri, S., Roume, J., Isidor, B., Lacombe, D., Delrue, M. A., … Attie-Bitach, T. (2015). New insights into genotype-phenotype correlation for GLI3 mutations. European Journal of Human Genetics, 23(1), 92-102. https://doi.org/10.1038/ejhg.2014.62</Citation>
        </Reference>
        <Reference>
          <Citation>Elizabeth, M., Verkerk, A., Hokken-Koelega, A., Verlouw, J., Argente, J., Pfaeffle, R., Visser, T. J., Peeters, R. P., &amp; De Graaff, L. (2020). Unique near-complete deletion of GLI2 in a patient with combined pituitary hormone deficiency and post-axial polydactyly. Growth Hormone &amp; IGF Research, 50, 35-41. https://doi.org/10.1016/j.ghir.2019.10.002</Citation>
        </Reference>
        <Reference>
          <Citation>Elson, E., Perveen, R., Donnai, D., Wall, S., &amp; Black, G. C. (2002). De novo GLI3 mutation in acrocallosal syndrome: Broadening the phenotypic spectrum of GLI3 defects and overlap with murine models. Journal of Medical Genetics, 39(11), 804-806. https://doi.org/10.1136/jmg.39.11.804</Citation>
        </Reference>
        <Reference>
          <Citation>Elward, C., Berg, J., Oberlin, J. M., &amp; Rohena, L. (2020). A case series of a mother and two daughters with a GLI2 gene deletion demonstrating variable expressivity and incomplete penetrance. Clinical Case Reports, 8(11), 2138-2144. https://doi.org/10.1002/ccr3.3085</Citation>
        </Reference>
        <Reference>
          <Citation>Firth, H. V., Wright, C. F., &amp; DDD Study. (2011). The deciphering developmental disorders (DDD) study. Developmental Medicine and Child Neurology, 53(8), 702-703. https://doi.org/10.1111/j.1469-8749.2011.04032.x</Citation>
        </Reference>
        <Reference>
          <Citation>Flemming, G. M., Klammt, J., Ambler, G., Bao, Y., Blum, W. F., Cowell, C., Donaghue, K., Howard, N., Kumar, A., Sanchez, J., Stobbe, H., &amp; Pfäffle, R. W. (2013). Functional characterization of a heterozygous GLI2 missense mutation in patients with multiple pituitary hormone deficiency. The Journal of Clinical Endocrinology and Metabolism, 98(3), E567-E575. https://doi.org/10.1210/jc.2012-3224</Citation>
        </Reference>
        <Reference>
          <Citation>França, M. M., Jorge, A. A., Carvalho, L. R., Costalonga, E. F., Vasques, G. A., Leite, C. C., Mendonca, B. B., &amp; Arnhold, I. J. (2010). Novel heterozygous nonsense GLI2 mutations in patients with hypopituitarism and ectopic posterior pituitary lobe without holoprosencephaly. The Journal of Clinical Endocrinology and Metabolism, 95(11), E384-E391. https://doi.org/10.1210/jc.2010-1050</Citation>
        </Reference>
        <Reference>
          <Citation>França, M. M., Jorge, A. A., Carvalho, L. R., Costalonga, E. F., Otto, A. P., Correa, F. A., Mendonca, B. B., &amp; Arnhold, I. J. (2013). Relatively high frequency of non-synonymous GLI2 variants in patients with congenital hypopituitarism without holoprosencephaly. Clinical Endocrinology, 78(4), 551-557. https://doi.org/10.1111/cen.12044</Citation>
        </Reference>
        <Reference>
          <Citation>Gregory, L. C., Gaston-Massuet, C., Andoniadou, C. L., Carreno, G., Webb, E. A., Kelberman, D., McCabe, M. J., Panagiotakopoulos, L., Saldanha, J. W., Spoudeas, H. A., Torpiano, J., Rossi, M., Raine, J., Canham, N., Martinez-Barbera, J. P., &amp; Dattani, M. T. (2015). The role of the sonic hedgehog signalling pathway in patients with midline defects and congenital hypopituitarism. Clinical Endocrinology, 82(5), 728-738. https://doi.org/10.1111/cen.12637</Citation>
        </Reference>
        <Reference>
          <Citation>Heussler, H. S., Suri, M., Young, I. D., &amp; Muenke, M. (2002). Extreme variability of expression of a sonic hedgehog mutation: Attention difficulties and holoprosencephaly. Archives of Disease in Childhood, 86(4), 293-296. https://doi.org/10.1136/adc.86.4.293</Citation>
        </Reference>
        <Reference>
          <Citation>Houge, G. (2015). Hvor går grensen mellom diagnostikk og forskning? [where is the boundary between diagnostics and research?]. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin, Ny Raekke, 135(18), 1632. https://doi.org/10.4045/tidsskr.15.0817</Citation>
        </Reference>
        <Reference>
          <Citation>Juanes, M., Di Palma, I., Ciaccio, M., Marino, R., Ramírez, P. C., Pérez Garrid, N., Maceiras, M., Lazzati, J. M., Rivarola, M. A., &amp; Belgorosky, A. (2016). Two novel heterozygous missense variations within the GLI2 gene in two unrelated argentine patients. Dos nuevas variantes heterocigotas en el gen GLI2 en dos pacientes argentinos no relacionados. Medicina, 76(4), 213-218.</Citation>
        </Reference>
        <Reference>
          <Citation>Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., Gauthier, L. D., Brand, H., Solomonson, M., Watts, N. A., Rhodes, D., Singer-Berk, M., England, E. M., Seaby, E. G., Kosmicki, J. A., … MacArthur, D. G. (2020). The mutational constraint spectrum quantified from variation in 141,456 humans. Nature, 581(7809), 434-443. https://doi.org/10.1038/s41586-020-2308-7</Citation>
        </Reference>
        <Reference>
          <Citation>Kremer Hovinga, I., Giltay, J. C., van der Crabben, S. N., Steyls, A., van der Kamp, H. J., &amp; Paulussen, A. (2018). Extreme phenotypic variability of a novel GLI2 mutation in a large family with panhypopituitarism and polydactyly: Clinical implications. Clinical Endocrinology, 89(3), 378-380. https://doi.org/10.1111/cen.13760</Citation>
        </Reference>
        <Reference>
          <Citation>Martín-Rivada, Á., Rodríguez-Contreras, F. J., Muñoz-Calvo, M. T., Güemes, M., González-Casado, I., Del Pozo, J. S., Campos-Barros, Á., &amp; Argente, J. (2019). A novel GLI2 mutation responsible for congenital hypopituitarism and polymalformation syndrome. Growth Hormone &amp; IGF Research, 44, 17-19. https://doi.org/10.1016/j.ghir.2018.12.002</Citation>
        </Reference>
        <Reference>
          <Citation>Meng, P., Zhao, H., Huang, W., Zhang, Y., Zhong, W., Zhang, M., Jia, P., Zhou, Z., Maimaitili, G., Chen, F., Zhang, J., &amp; Lin, J. (2019). Three GLI2 mutations combined potentially underlie non-syndromic cleft lip with or without cleft palate in a Chinese pedigree. Molecular Genetics &amp; Genomic Medicine, 7(9), e714. https://doi.org/10.1002/mgg3.714</Citation>
        </Reference>
        <Reference>
          <Citation>Palencia-Campos, A., Martínez-Fernández, M. L., Altunoglu, U., Soto-Bielicka, P., Torres, A., Marín, P., Aller, E., Şentürk, L., Berköz, Ö., Yıldıran, M., Kayserili, H., Gil-Camarero, E., Colli-Lista, G., Sanchís-Calvo, A., Carretero, A., ECEMC Working Group on Polydactyly, Guillén-Navarro, E., López-González, V., Ballesta-Martínez, M., … Ruiz-Pérez, V. L. (2020). Heterozygous pathogenic variants in GLI1 are a common finding in isolated postaxial polydactyly A/B. Human Mutation, 41(1), 265-276. https://doi.org/10.1002/humu.23921</Citation>
        </Reference>
        <Reference>
          <Citation>Rahimov, F., Ribeiro, L. A., de Miranda, E., Richieri-Costa, A., &amp; Murray, J. C. (2006). GLI2 mutations in four Brazilian patients: How wide is the phenotypic spectrum? American Journal of Medical Genetics. Part A, 140(23), 2571-2576. https://doi.org/10.1002/ajmg.a.31370</Citation>
        </Reference>
        <Reference>
          <Citation>Roessler, E., Du, Y. Z., Mullor, J. L., Casas, E., Allen, W. P., Gillessen-Kaesbach, G., Roeder, E. R., Ming, J. E., Ruiz i Altaba, A., &amp; Muenke, M. (2003). Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13424-13429. https://doi.org/10.1073/pnas.2235734100</Citation>
        </Reference>
        <Reference>
          <Citation>Roessler, E., Ermilov, A. N., Grange, D. K., Wang, A., Grachtchouk, M., Dlugosz, A. A., &amp; Muenke, M. (2005). A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2. Human Molecular Genetics, 14(15), 2181-2188. https://doi.org/10.1093/hmg/ddi222</Citation>
        </Reference>
        <Reference>
          <Citation>Shirakawa, T., Nakashima, Y., Watanabe, S., Harada, S., Kinoshita, M., Kihara, T., Hamasaki, Y., Shishido, S., Yoshiura, K. I., Moriuchi, H., &amp; Dateki, S. (2018). A novel heterozygous GLI2 mutation in a patient with congenital urethral stricture and renal hypoplasia/dysplasia leading to end-stage renal failure. CEN Case Reports, 7(1), 94-97. https://doi.org/10.1007/s13730-018-0302-9</Citation>
        </Reference>
        <Reference>
          <Citation>Solomon, B. D., Pineda-Alvarez, D. E., Gropman, A. L., Willis, M. J., Hadley, D. W., &amp; Muenke, M. (2012). High intellectual function in individuals with mutation-positive microform holoprosencephaly. Molecular Syndromology, 3(3), 140-142. https://doi.org/10.1159/000341373</Citation>
        </Reference>
        <Reference>
          <Citation>Tavtigian, S. V., Greenblatt, M. S., Harrison, S. M., Nussbaum, R. L., Prabhu, S. A., Boucher, K. M., Biesecker, L. G., &amp; ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI). (2018). Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genetics in Medicine, 20(9), 1054-1060. https://doi.org/10.1038/gim.2017.210</Citation>
        </Reference>
        <Reference>
          <Citation>Tunyasuvunakool, K., Adler, J., Wu, Z., Green, T., Zielinski, M., Žídek, A., Bridgland, A., Cowie, A., Meyer, C., Laydon, A., Velankar, S., Kleywegt, G. J., Bateman, A., Evans, R., Pritzel, A., Figurnov, M., Ronneberger, O., Bates, R., Kohl, S., … Hassabis, D. (2021). Highly accurate protein structure prediction for the human proteome. Nature, 596(7873), 590-596. https://doi.org/10.1038/s41586-021-03828-1</Citation>
        </Reference>
        <Reference>
          <Citation>Vaaralahti, K., Raivio, T., Koivu, R., Valanne, L., Laitinen, E. M., &amp; Tommiska, J. (2012). Genetic overlap between Holoprosencephaly and Kallmann syndrome. Molecular Syndromology, 3(1), 1-5. https://doi.org/10.1159/000338706</Citation>
        </Reference>
        <Reference>
          <Citation>Vishnopolska, S. A., Mercogliano, M. F., Camilletti, M. A., Mortensen, A. H., Braslavsky, D., Keselman, A., Bergadá, I., Olivieri, F., Miranda, L., Marino, R., Ramírez, P., Pérez Garrido, N., Patiño Mejia, H., Ciaccio, M., Di Palma, M. I., Belgorosky, A., Martí, M. A., Kitzman, J. O., Camper, S. A., &amp; Pérez-Millán, M. I. (2021). Comprehensive identification of pathogenic gene variants in patients with neuroendocrine disorders. The Journal of Clinical Endocrinology and Metabolism, 106(7), 1956-1976. https://doi.org/10.1210/clinem/dgab177</Citation>
        </Reference>
        <Reference>
          <Citation>Yousaf, M., Ullah, A., Azeem, Z., Isani Majeed, A., Memon, M. I., Ghous, T., Basit, S., &amp; Ahmad, W. (2020). Novel heterozygous sequence variant in the GLI1 underlies postaxial polydactyly. Congenital Anomalies, 60(4), 115-119. https://doi.org/10.1111/cga.12361</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
